STIM Neuronetics, Inc.: Operating Margin

Corporate emblem and logo of Neuronetics, Inc (STIM)

Neuronetics, Inc. (STIM) leads the non-drug treatment of depression through its NeuroStar system. The operating margin trajectory confirms this potential, with the indicator currently at -9.40. High patient confidence supports the company's image as a lifesaver. However, the growth of alternative therapy methods creates pressure on the business, although an extensive installed equipment base ensures a stable cash flow.

STIM: Neuronetics Operating Margin 07/04/2022 - 11/19/2026

Neuronetics, Inc. - analytical breakdowns and key metrics (STIM)

- share price and consensus valuation forecast:
Fundamental company analysis:STIM, Neuronetics Inc.
Brand item of Neuronetics, Inc

Operating margin reflects the share of profit from core activities relative to revenue before interest and taxes. By analyzing the operating profit spread, an investor determines cost management efficiency and the internal profitability of the business. This indicator reveals the company's ability to generate cash flow from basic operations. For Neuronetics, Inc. (STIM), this metric depends on the cost of maintaining a qualified staff of medical technicians. Investments in personnel training directly impact operational efficiency.

Competitors of Neuronetics, Inc. (STIM)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|Stereotaxis Inc (STXS) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)